NASDAQ 100 % ()
FTSE 100 % ()
DOLLAR INDEX % ()
BTC/USD % ()
EUR/USD % ()
GBP/USD % ()
GOLD % ()
SILVER % ()
CRUDE OIL % ()

TMO

Thermo Fisher Scientific Inc New York Stock Exchange
$514.99
Open: $0.00 High: $0.00 Low: $0.00 Close: $0.00
Range: 0 - 0
Volume: 0
Market: Closed
Powered by Finage Stock APIDelayed data
TMO
Thermo Fisher Scientific Inc 168 Third Avenue Waltham MA, 2451 http://www.thermofisher.com
Thermo Fisher Scientific Inc is a healthcare company. It offers analytical instruments, laboratory equipment, software, services, consumables, reagents and chemicals.
  • CEO: Marc N. Casper
  • Employees: 70,000
  • Sector: Healthcare
  • Industry: Medical Diagnostics & Research
TMO News
Latest news about the TMO
  • Teladoc, Intuitive Surgical, TMO Stock Near Buy Points As Covid Testing Ramps Up, Vaccines Lift Outlook

    Thermo Fisher, Catalent, Teladoc Health, One Medical and ISRG stock are rallying on Covid testing and coronavirus vaccine rollouts and post-pandemic hopes.

    View More →
  • Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know

    Thermo Fisher Scientific (TMO) closed at $503.14 in the latest trading session, marking a +1.25% move from the prior day.

    View More →
  • Thermo Fisher Scientific Acquires Viral Vector Manufacturing Business from Novasep

    Thermo Fisher Scientific Inc., (NYSE: TMO), the world leader in serving science, and Groupe Novasep SAS (Novasep), a leading supplier of services and technologies for the life sciences industry, today announced that Thermo Fisher has completed the acquisition of Henogen S.A., Novasep's viral vector manufacturing business in Belgium for approximately €725 million in cash.

    View More →
  • The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health

    The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health

    View More →
  • Thermo Fisher (TMO) Rides on End Market Growth Amid Pandemic

    Thermo Fisher (TMO) launches Amplitude Solution to automate high-throughput PCR-based testing and significantly expands capacity for viral transport media production in Europe.

    View More →
  • Top Analyst Reports for Amazon, Thermo Fisher & Eli Lilly

    Top Analyst Reports for Amazon, Thermo Fisher & Eli Lilly

    View More →
  • Thermo Fisher Scientific (NYSE:TMO) Shareholders Have Enjoyed An Impressive 270% Share Price Gain

    When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...

    View More →
  • A Trio of Stock Picks for Growth-Oriented Investors

    These companies have improved quarterly sales and profits recently

    View More →
  • FDA identifies 3 COVID-19 tests that may be impacted by new variant

    The Food and Drug Administration on Friday said it has identified three authorized COVID-19 tests in the U.S. that may be affected by new SARS-CoV-2 mutations, including the B.1.1.7 variant first pinpointed in the United Kingdom. These tests are Applied DNA Sciences Inc. Linea COVID-19 Assay Kit, the privately held Mesa BioTech Inc.'s Accula, and Thermo Fisher Scientic Inc.'s TaqPath COVID-19 Combo Kit. The regulator said false-negative results may occur in some instances of viral mutations but it expects the impact of the mutations on COVID-19 testing accuracy is "low." "Importantly, the detection pattern that appears with the TaqPath and Linea diagnostic tests when certain genetic variants are present may help with early identification of new variants in patients to reduce further spread of infection," the FDA said. The FDA is also evaluating all molecular COVID-19 tests that received emergency use authorization. Shares of Thermo Fisher were up 1.7% in trading on Friday, while Applied DNA Sciences' stock gained 2.8%. The S&P 500 is up 0.2%.

    View More →
  • Coronavirus variants may lead to false negative results with molecular tests - FDA

    Genetic variants of the novel coronavirus, including the one found in UK, could impact the performance of some molecular COVID-19 tests and lead to false negative results, the U.S. Food and Drug Administration (FDA) said on Friday. The agency has alerted clinical laboratory staff and health care providers to the possible false negative results from any molecular test, and has asked them to consider such results in combination with clinical observations, and repeat testing with a different test if COVID-19 is still suspected. The FDA, however, said the risk that these mutations will impact overall testing accuracy is low.

    View More →
  • Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know

    Thermo Fisher Scientific (TMO) closed at $485.21 in the latest trading session, marking a +1.57% move from the prior day.

    View More →
  • Thermo Fisher Scientific Offers Financial Flexibility with New Managed Equipment Solutions

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced the launch of Managed Equipment Solutions, a new subscription-based offering that bundles instrument and equipment procurement with consumables, applications support, software, training and extended service in a convenient and cost-efficient agreement.

    View More →
  • Thermo Fisher Scientific to Present at 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021, at 3:40 p.m. (EDT). Among other topics, Mr. Casper will provide the company's current perspective on the impact of the COVID-19 pandemic and expectations for future financial performance.

    View More →
  • Thermo Fisher Scientific to Hold Earnings Conference Call on Monday, February 1, 2021

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the fourth quarter and full year 2020 before the market opens on Monday, February 1, 2021, and will hold a conference call on the same day at 8:30 a.m. EDT.

    View More →
  • Why the Earnings Surprise Streak Could Continue for Thermo Fisher (TMO)

    Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

    View More →
  • 15 Largest Medical Device Companies in the World

    In this article, we are going to list the 15 largest medical device companies in the world. Click to skip ahead and jump to the 5 largest medical device companies in the world. What are the largest medical device companies in 2021? The sudden emergence of serious infections such as the novel coronavirus is expected to drive […]

    View More →
  • Thermo Fisher Scientific Announces Redemption of Senior Notes

    Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that on December 31, 2020, it will give notice of its intention to redeem the following Senior Notes, representing an aggregate total principal amount of approximately $2.6 billion, on January 15, 2021 (the "Redemption Date"):

    View More →
  • Thermo Fisher Scientific (TMO) Stock Sinks As Market Gains: What You Should Know

    Thermo Fisher Scientific (TMO) closed the most recent trading day at $458.34, moving -1.47% from the previous trading session.

    View More →
  • This Top CEO's Rock-Solid Company Acts Like A Teenager

    The company may be more than 60 years old. But Thermo Fisher Scientific CEO Marc Casper says it acts more like a fast-growing teenager.

    View More →
  • Medtronic (MDT) Gets Canada Nod for Micra AV to Treat AV Block

    With the approval, Medtronic (MDT) aims to strengthen its Cardiac and Vascular Group business globally.

    View More →